Short Cases In Clinical Neurology

Body mass index (BMI) has been found to have an impact on neurodegenerative diseases such as Parkinson's disease (PD). Several studies suggested that patients with PD have a lower BMI compared with controls. However, some studies indicated the differences between patients and controls as statistically insignificant.

Body mass index in patients with Parkinson's disease: a systematic review - PubMed

*New treatment addresses multiple aspects of MND*
Motor neurone disease, which affects over 5,000 people in the *UK* at any given time, is characterised by progressive muscle wasting.

Current treatments only address symptoms, but *Ellorarxine* shows potential to tackle the underlying causes of the disease.

The study revealed that Ellorarxine demonstrates antioxidant and anti-inflammatory effects, even at very low concentrations.

It was found to increase the expression of key proteins, promote neurite growth, and improve mitochondrial health – all crucial factors in combating MND.

What sets Ellorarxine apart is its ability to address what researchers call the "3Ns" – neuroprotection, neuroplasticity, and neurorepair. This comprehensive approach is rare in potential MND treatments and could be a game-changer in the field.
Source: A study by Durham University

Shout out to my newest followers! Excited to have you onboard! Jones Illuminati, W.a. Inan, Shahrier Sakib, Anwar Hossain, Md. Suman Hossain, Kaniz Fatema Shetu, MD Abdul Momen, Abul Fazal Islam, Manowar Tareque Tareque, Nbmch Ortho, Sayma Nur, Tasmia Ferdous Othoi, Shohan Mridha, মোহাম্মদ তজমুল শেখ, Munaish Maharaj, Maria Binta Mahbub, Fariha Islam, Hemal Chowdhury, फिवल ऐडश, Zayed Bin Azad Sami, Maria Mahjabin, Favour Mbakwem, Shah Fajle Elahi, Alia Rahman, Fatema Faahi, Md Moniruzzaman Lanin, Mim Mim, Rowzatul Ferfous, জান্নাত নাঈম, DrMomtazul Haque, Sumaiya Islam